Whitehawk Therapeutics, Inc.
WHWK · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $7.14M | $26.0M | −72.5% |
| Operating income | −$114M | −$67.5M | −69.6% |
| Net income | −$20.6M | −$63.7M | +67.7% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$22.9M | −$19.5M | −17.4% |
| Net income | −$21.2M | −$17.7M | −19.8% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Whitehawk's revenue in FY2025?
- $7.14M in FY2025 (Fiscal year ended Dec 31, 2025), −72.5% vs $26.0M a year earlier, per its 10-K filed Mar 2026.
- Was Whitehawk profitable in FY2025?
- No: net income was −$20.6M and operating income −$114M in FY2025.
- What was Whitehawk's revenue in Q3 2026?
- $0K (n/a vs a year earlier), per its Form 10-Q filed Nov 9, 2026.